Azora Therapeutics, Inc. (DE)
For the period ended Mar 31, 2025. Filed May 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
(a) Unregistered Sales of Equity Securities
We did not sell any equity securities during the three months ended March 31, 2025 in transactions that were not registered under the Securities Act other than as disclosed in our filings with the SEC and other than the issuance on January 27, 2025, of 100,000 shares of common stock to a vendor and cash of $4,970 in consideration for services rendered valued at $100,000. The shares were exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.
(b) Use of Proceeds
(c) Issuer Purchases of Equity Securities
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.